Search results for "Lewy body"

showing 10 items of 20 documents

Nasal chemosensory tests: biomarker between dementia with Lewy bodies and Parkinson disease dementia.

2020

BACKGROUND: Dementia with Lewy bodies (DLB) and Parkinson disease dementia (PDD) are progressive and disabling neurodegenerative disorders, which are often misdiagnosed due to theirs overlapping clinical and paraclinical features. Nevertheless, their adequate management requires an accurate differential diagnosis. The main aim of this study was to investigate the usefulness of olfactory and trigeminal nasal testing for the differential diagnosis between DLB and PDD. METHODS: Odor thresholds to three odorants differentially activating the olfactory and trigeminal systems were assessed in patients with DLB, PDD and healthy controls (n = 20 per group). RESULTS: Odor thresholds were significant…

Lewy Body Diseasemedicine.medical_specialtyDiseasebehavioral disciplines and activitiesGastroenterologyDiagnosis Differential03 medical and health sciences0302 clinical medicineInternal medicinemental disordersmedicineDementiaHumansIn patient030223 otorhinolaryngologyCanonical discriminant analysisDetection thresholdDementia with Lewy bodiesbusiness.industryParkinson DiseaseGeneral Medicinemedicine.diseasenervous system diseasesSmellOtorhinolaryngologyBiomarker (medicine)Differential diagnosisbusinessBiomarkersRhinology
researchProduct

Analysis of the LRP10 gene in patients with Parkinson's disease and dementia with Lewy bodies from Southern Italy

2020

Recently, the LRP10 gene has been associated with Parkinson's disease (PD), Parkinson's disease with dementia (PDD), and dementia with Lewy bodies (DLB). The aim of the present study was to evaluate the presence of mutations of the LRP10 gene in patients with PD or DLB from Southern Italy. Sequencing analysis revealed only 2 missense and 3 synonymous variants in patients and control subjects and a rare variant p.L622F in a PD case. These results suggest that LRP10 mutations are not a frequent cause of PD and DLB in Southern Italy.

Lewy Body Diseasemedicine.medical_specialtyNeurologyParkinson's diseaseLRP10 . Parkinson’s disease . Dementia with Lewy bodiesDermatologyDiseasebehavioral disciplines and activities03 medical and health sciences0302 clinical medicineAlzheimer DiseaseInternal medicineDementia with Lewy bodies; LRP10; Parkinson's disease.mental disordersmedicineDementiaMissense mutationHumans030212 general & internal medicineNeuroradiologyDementia with Lewy bodiesbusiness.industryParkinson DiseaseGeneral Medicinemedicine.diseasenervous system diseasesPsychiatry and Mental healthItalyMutationSettore MED/26 - NeurologiaNeurology (clinical)Neurosurgerybusiness030217 neurology & neurosurgery
researchProduct

Presence phenomena in parkinsonian disorders: Phenomenology and neuropsychological correlates.

2020

Introduction The feeling of a presence that occurs in the absence of objectively identifiable stimuli is common in parkinsonian disorders. Although previously considered benign and insignificant, recent evidence suggests that presence phenomena may act as the gateway to more severe hallucinations and dementia. Despite this, we still know relatively little about these phenomena. Objective To examine parkinsonian disorder patients' subjective experience of presence phenomena, and retrospectively analyse their cognitive correlates, in order to elucidate the emergence of information processing deficits in parkinsonian disorders. Methods/design 25 patients who endorsed presence phenomena were as…

Lewy Body Diseasemedicine.medical_specialtyParkinson's diseaseHallucinationsmedia_common.quotation_subjectAudiologyNeuropsychological TestsVisual processingParkinsonian DisordersmedicineDementiaHumansmedia_commonRetrospective StudiesDementia with Lewy bodiesNeuropsychologyCognitionParkinson Diseasemedicine.diseasePsychiatry and Mental healthFeelingAnxietyGeriatrics and Gerontologymedicine.symptomPsychologyCognition DisordersInternational journal of geriatric psychiatryREFERENCES
researchProduct

Recognition by familiarity is preserved in Parkinson's without dementia and Lewy-Body disease.

2010

Objective The retrieval deficit hypothesis states that the lack of deficit in recognition often observed in patients with Parkinson's disease is because of the low retrieval requirements of the task, given that these patients have retrieval and not encoding deficits. To test this hypothesis we investigated recognition memory by familiarity in Parkinson's patients and in patients with Lewy Bodies disease and Parkinson with dementia. Method We analyzed to what extent the experimental groups were able to recognize by familiarity in a typical yes/no recognition memory task. The experimental groups were patients with early nondemented Parkinson's disease, advanced nondemented Parkinson's disease…

Lewy Body Diseasemedicine.medical_specialtyParkinson's diseaseMatched-Pair AnalysisAudiologyCentral nervous system diseaseDegenerative diseaseReference ValuesmedicineDementiaHumansPsychiatryRecognition memoryAgedAnalysis of VarianceDementia with Lewy bodiesMemoriaCognitionParkinson DiseaseRecognition Psychologymedicine.diseaseNeuropsychology and Physiological PsychologyCase-Control StudiesMental RecallTrastorns de la memòria en la vellesaDementiaPsychologyNeuropsychology
researchProduct

The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design

2017

Dementia with Lewy bodies (DLB) causes elevated outlays for the National Health Systems due to high institutionalization rate and patients' reduced quality of life and high mortality. Furthermore, DLB is often misdiagnosed as Alzheimer's disease. These data motivate harmonized multicenter longitudinal cohort studies to improve clinical management and therapy monitoring. The Italian DLB study group of the Italian Neurological Society for dementia (SINdem) developed and emailed a semi-structured questionnaire to 572 national dementia centers (from primary to tertiary) to prepare an Italian large longitudinal cohort. The questionnaire surveyed: (1) prevalence and incidence of DLB; (2) clinical…

Lewy Body Diseasemedicine.medical_specialtyPediatricsDementia with Lewy bodieDementia with Lewy bodiesDermatologyCohort StudiesDiagnosis Differential03 medical and health sciences0302 clinical medicineQuality of lifeAlzheimer DiseaseSurveys and Questionnairesmental disordersStandardization of diagnostic proceduresDiagnosisDementia with Lewy bodies; Standardization of diagnostic procedures; Survey; Alzheimer Disease; Cohort Studies; Diagnosis Differential; Disease Management; Humans; Italy; Lewy Body Disease; Research Design; Surveys and Questionnaires; 2708; Neurology (clinical); Psychiatry and Mental HealthmedicineDementiaHumans030212 general & internal medicineSurveyMED/01 - STATISTICA MEDICAMED/26 - NEUROLOGIAbusiness.industryDementia with Lewy bodiesDisease ManagementStandardization of diagnostic procedureGeneral Medicinemedicine.diseaseSettore MED/26 - NEUROLOGIADementia with Lewy bodies; Standardization of diagnostic procedures; Survey; 2708; Neurology (clinical); Psychiatry and Mental HealthItalyResearch DesignPsychiatry and Mental HealthCohortDifferentialPhysical therapyDeliriumNeurology (clinical)Alzheimer's diseasemedicine.symptombusiness030217 neurology & neurosurgeryFrontotemporal dementiaCohort study2708
researchProduct

Measuring network disruption in neurodegenerative diseases: New approaches using signal analysis

2019

Advanced neuroimaging has increased understanding of the pathogenesis and spread of disease, and offered new therapeutic targets. MRI and positron emission tomography have shown that neurodegenerative diseases including Alzheimer’s disease (AD), Lewy body dementia (LBD), Parkinson’s disease (PD), frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) are associated with changes in brain networks. However, the underlying neurophysiological pathways driving pathological processes are poorly defined. The gap between what imaging can discern and underlying pathophysiology can now be addressed by advanced techniques that explore the cortical neural synchro…

Lewy Body Diseasemedicine.medical_treatmentElectroencephalographysurgery03 medical and health sciences0302 clinical medicineNeuroimagingAlzheimer DiseasemedicineDementiaHumans1506Amyotrophic lateral sclerosisNeurodegeneration030304 developmental biologyneurology (clinical)0303 health sciencesLewy bodymedicine.diagnostic_testbusiness.industryAmyotrophic Lateral Sclerosissurgery; neurology (clinical); psychiatry and mental healthMagnetoencephalographyElectroencephalographyNeurodegenerative DiseasesParkinson DiseaseMagnetoencephalographymedicine.diseaseTranscranial Magnetic Stimulation3. Good healthTranscranial magnetic stimulationpsychiatry and mental healthFrontotemporal DementiaNerve NetbusinessNeuroscience030217 neurology & neurosurgeryFrontotemporal dementiaJournal of Neurology, Neurosurgery, and Psychiatry
researchProduct

Amygdala pathology in Parkinson's disease.

1994

The amygdala undergoes severe pathological changes during the course of Parkinson's disease (PD). Lewy bodies and Lewy neurites are distributed in a specific manner throughout the nuclear complex. The lesional pattern displays only minor interindividual variation. The most prominent changes occur in the accessory cortical and central nuclei. The cortical, accessory basal and granular nuclei show less severe alterations, while the basal and lateral nuclei, as well as the intercalated cell masses, generally remain uninvolved. The amygdala receives a broad range of afferents, allowing integration of exteroceptive information with interoceptive data. It generates major projections to the isocor…

MalePathologymedicine.medical_specialtyParkinson's diseaseLewy bodyHippocampusParkinson DiseaseBiologyMiddle Agedmedicine.diseaseAmygdalaAmygdalaPathology and Forensic MedicineCellular and Molecular NeuroscienceBasal (phylogenetics)Limbic systemmedicine.anatomical_structureDegenerative diseasemedicineHumansFemaleNeurology (clinical)Prefrontal cortexAgedActa neuropathologica
researchProduct

Misidentification Delusions : prevalence in different types of dementia and validation of a structured Questionnaire

2016

International audience; Misidentification delusions (MDs) are considered relatively rare psychopathologic phenomena that may occur within the context of psychiatric or neurological conditions. The purpose of this study was to assess the prevalence of MD in different types of dementia, correlate the presence of MD with demographic and clinical variables, and validate a specific questionnaire. We examined 146 subjects with Alzheimer disease, 21 with Lewy body dementia, 6 with frontotemporal dementia, and 13 with vascular dementia (subcortical type), who were consecutively enrolled in the study from 2 Memory Clinics. Patients had a mean age of 78.7±6.4 years and an Mini-Mental State Examinatio…

Malemedicine.medical_specialtyhome misidentificationReduplicative paramnesia[ SCCO.PSYC ] Cognitive science/PsychologyContext (language use)reduplicative paramnesiaDelusions[ SDV.NEU.SC ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive Sciences03 medical and health sciences0302 clinical medicineDelusionSurveys and QuestionnairesPrevalenceHumansMedicineDementiaVascular dementiaPsychiatryAgedPsychiatric Status Rating ScalesLewy bodybusiness.industry[SCCO.NEUR]Cognitive science/Neuroscience[SDV.NEU.SC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive Sciencesmedicine.disease030227 psychiatrymisidentification delusionsPsychiatry and Mental healthClinical PsychologyCapgras syndrome[ SCCO.NEUR ] Cognitive science/Neuroscience[SCCO.PSYC]Cognitive science/PsychologyDementiaFemaleGeriatrics and GerontologyAlzheimer's diseasemedicine.symptomAlzheimer diseaseLewy body dementiabusinessGerontology030217 neurology & neurosurgeryClinical psychologyFrontotemporal dementia
researchProduct

HIGH PROPORTION OF DEMENTIA WITH LEWY BODIES IN THE POSTMORTEMS OF A MENTAL HOSPITAL IN GERMANY

1997

Objective. Dementia with Lewy bodies (DLB) is under-recognized in Germany. No data on the number of patients suffering from this condition in Germany are available at present. We were interested in the proportion of DLB in the postmortems of demented inpatients in the care of a psychogeriatric service. Design. In a retrospective study we examined consecutive postmortems of inpatients who died in one mental hospital. Setting. A suburban and rural old age psychiatry service in Germany. Patients. 103 consecutive postmortems had been performed from 9/1987 to 6/1995. Fifty-nine (57.3%) of all cases warranted the clinical diagnosis of dementia (DSM-III-R). Measures. The causes of dementia were ex…

Pediatricsmedicine.medical_specialtyLewy bodyDementia with Lewy bodiesbusiness.industryIncidence (epidemiology)medicine.diseasePsychiatry and Mental healthnervous systemmental disordersEpidemiologymedicineDementiaPsychiatric hospitalGeriatrics and GerontologyAlzheimer's diseasePsychiatrybusinessVascular dementiaInternational Journal of Geriatric Psychiatry
researchProduct

Fabry Disease With Concomitant Lewy Body Disease

2019

AbstractAlthough Gaucher disease can be accompanied by Lewy pathology (LP) and extrapyramidal symptoms, it is unknown if LP exists in Fabry disease (FD), another progressive multisystem lysosomal storage disorder. We aimed to elucidate the distribution patterns of FD-related inclusions and LP in the brain of a 58-year-old cognitively unimpaired male FD patient suffering from predominant hypokinesia. Immunohistochemistry (CD77, α-synuclein, collagen IV) and neuropathological staging were performed on 100-µm sections. Tissue from the enteric or peripheral nervous system was unavailable. As controls, a second cognitively unimpaired 50-year-old male FD patient without LP or motor symptoms and 3…

complications [Lewy Body Disease]MalePathologyAutopsyDisease0302 clinical medicineHypokinesiapathology [Brain]Lysosomal storage diseasespathology [Neurons]metabolism [alpha-Synuclein]metabolism [Fabry Disease]pathology [Astrocytes]Neuronsα-Synuclein0303 health sciencesParkinsonismTrihexosylceramidesBrainGeneral MedicineMiddle AgedParkinson diseasecomplications [Fabry Disease]Neurologymetabolism [Neurons]alpha-Synucleinmedicine.symptomLewy Body Diseasemedicine.medical_specialtymetabolism [Lewy Body Disease]Context (language use)Substantia nigrametabolism [Trihexosylceramides]Pathology and Forensic Medicineblood supply [Brain]03 medical and health sciencesCellular and Molecular Neuroscienceα-Galactosidase AmedicineHumansddc:610030304 developmental biologypathology [Lewy Bodies]Fabry diseasebusiness.industryPars compactapathology [Lewy Body Disease]Lewy bodies/neuritesOriginal Articlesmetabolism [Lewy Bodies]medicine.diseaseFabry diseasemetabolism [Brain]AstrocytesLewy BodiesNeurology (clinical)CD77pathology [Fabry Disease]business030217 neurology & neurosurgeryJournal of Neuropathology and Experimental Neurology
researchProduct